Simone Handler-Hutchinson

Center for Health & Pharmaceutical Law & Policy

One Newark Center

Newark, NJ 07102-5210

United States

Seton Hall School of Law

Director, HCCCP & Faculty Fellow

One Newark Center

Newark, NJ 07102

United States

http://law.shu.edu

SCHOLARLY PAPERS

3

DOWNLOADS

526

CITATIONS

2

Scholarly Papers (3)

1.

'Monitoring' Corporate Corruption: DOJ's Use of Deferred Prosecution Agreements

American Journal of Law & Medicine, 2009, Seton Hall Public Law Research Paper No. 1317072
Number of pages: 43 Posted: 17 Dec 2008 Last Revised: 10 Mar 2009
Kathleen Boozang and Simone Handler-Hutchinson
Seton Hall School of Law and Center for Health & Pharmaceutical Law & Policy
Downloads 303 (98,825)
Citation 2

Abstract:

Loading...

corporate compliance, deferred prosecution agreement, transparency, corporate monitor, pretrial diversion

2.

Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight

White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School
Number of pages: 62 Posted: 03 Dec 2009 Last Revised: 11 Feb 2014
Seton Hall School of Law, Seton Hall University School of Law, Seton Hall University - Center for Health & Pharmaceutical Law & Policy, affiliation not provided to SSRN, University of Chicago - MacLean Center for Clinical Medical Ethics, Center for Health & Pharmaceutical Law & Policy and Seton Hall University - Center for Health & Pharmaceutical Law & Policy
Downloads 158 (184,901)
Citation 1

Abstract:

Loading...

conflict of interest, pharmaceutical, clinical trials

3.

The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research

Number of pages: 36 Posted: 06 Dec 2010
Seton Hall School of Law, Seton Hall University School of Law, affiliation not provided to SSRN, Center for Health & Pharmaceutical Law & Policy and Seton Hall University - Center for Health & Pharmaceutical Law & Policy
Downloads 65 (338,342)

Abstract:

Loading...

conflicts of interest, clinical trials, informed consent, transparency